πŸ‡ΊπŸ‡Έ FDA
Patent

US 8293929

Processes and intermediates

granted A61PA61P25/28A61P29/00

Quick answer

US patent 8293929 (Processes and intermediates) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P25/28, A61P29/00, A61P35/00, A61P43/00